Trials / Completed
CompletedNCT02326766
Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated effects of red ginseng consumption on blood pressure (BP) and fasting plasma metabolomes.
Detailed description
A randomized, double-blind, placebo-controlled study was conducted on nonobese, nondiabetic and prehypertensive subjects. Over a 12 week test period, the red ginseng group (n=31) consumed 10 capsules (total 5g) daily containing red ginseng, while the placebo group (n=31) consumed the same product without red ginseng. Fasting plasma metabolomes were profiled using UPLC-LTQ-Orbitrap mass spectrometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | KRG | 5g Korea red ginseng (KRG) |
| DIETARY_SUPPLEMENT | Placebo | 5g placebo |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-02-01
- Completion
- 2012-03-01
- First posted
- 2014-12-29
- Last updated
- 2014-12-29
Source: ClinicalTrials.gov record NCT02326766. Inclusion in this directory is not an endorsement.